Previous research has recognized that saliva contains factors which inhibit HIV-1 production or infectivity. The salivary HIV-inhibitory factors (SHIF) can be derived from salivary glands and immune systems such as lymphocytes and macrophages. Four hypotheses will be tested in the proposal: 1) There are unidentified SHIFs in addition to the reported factor such as secretory leukocyte protease-inhibitor (SLPI); 2) certain SHIFs (HIV bp) bind to viral envelop proteins and inhibit viral entry; 3) chemokines constitute one of SHIF; and 4) certain SHIFs compete with HIV-1 for receptors on T cells, or monocytes. To test the hypotheses, five specific aims are proposed. 1. To isolate and characterized SHIF cDNA from a subtractive expression cDNA libraries of parotid and submandibular/sublingual salivary glands. 2. To isolate and characterize cDNAs whose protein products (HIV bp) bind to HIV-1 gp120, from parotid and submandibular salivary gland cDNA libraries by yeast-based two-hybrid system. 3. To determine whether normal or AIDS patient's saliva contain macrophage or T cell-derived chemokines which display HIV-1-suppressive activities. 4. To determine whether the binding of HIV bp to gp120 inhibits HIV-1 attachment or subsequent stages of HIV-1 life cycle. 5. To determine whether certain SHIF such as chemokines and SLPI compete with HIV-1 for the binding to CD4+ T cells or monocytes, or inhibit other stage of HIV-1 life cycle. Identification of natural HIV-inhibitory defectors and determination of their action mechanisms are necessary for effective treatment of AIDS. Since individual isolates of HIV-1 shows difference in sensitivity to a certain inhibitory factors, identification of more inhibitory factors will aid in developing treatment modalities of AIDS.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
5R01DE012156-02
Application #
2458668
Study Section
Special Emphasis Panel (ZDE1-YS (31))
Project Start
1996-09-30
Project End
2001-07-31
Budget Start
1997-08-01
Budget End
1998-07-31
Support Year
2
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Indiana University-Purdue University at Indianapolis
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
005436803
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Lee, Won-Ha; Kim, Se-Hwa; Jeong, Euy Myoung et al. (2002) A novel chemokine, Leukotactin-1, induces chemotaxis, pro-atherogenic cytokines, and tissue factor expression in atherosclerosis. Atherosclerosis 161:255-60
Youn, Byung-Soo; Lim, Chae Lyul; Shin, Man Kyun et al. (2002) An intronic silencer of the mouse perforin gene. Mol Cells 13:61-8
Blazar, B R; Kwon, B S; Panoskaltsis-Mortari, A et al. (2001) Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients. J Immunol 166:3174-83
Youn, B S; Yu, K Y; Alkhatib, G et al. (2001) The seventh transmembrane domain of cc chemokine receptor 5 is critical for MIP-1beta binding and receptor activation: role of MET 287. Biochem Biophys Res Commun 281:627-33
Seo, S K; Gebhardt, B M; Lim, H Y et al. (2001) Murine keratocytes function as antigen-presenting cells. Eur J Immunol 31:3318-28
Lee, W H; Kim, S H; Lee, Y et al. (2001) Tumor necrosis factor receptor superfamily 14 is involved in atherogenesis by inducing proinflammatory cytokines and matrix metalloproteinases. Arterioscler Thromb Vasc Biol 21:2004-10
Yu, K Y; Kwon, B; Ni, J et al. (1999) A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J Biol Chem 274:13733-6
Kwon, B; Yu, K Y; Ni, J et al. (1999) Identification of a novel activation-inducible protein of the tumor necrosis factor receptor superfamily and its ligand. J Biol Chem 274:6056-61
Vinay, D S; Kwon, B S (1999) Relative abilities of 4-1BB (CD137) and CD28 to co-stimulate the response of cytokine deflected Th1 and Th2 cells. Immunobiology 200:246-63
Kim, Y J; Mantel, P L; June, C H et al. (1999) 4-1BB costimulation promotes human T cell adhesion to fibronectin. Cell Immunol 192:13-23

Showing the most recent 10 out of 19 publications